Liechtenstein Business Focus
SEE OTHER BRANDS

Exploring the business and economy news of Liechtenstein

Liechtenstein Business Focus: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Liechtenstein Business Focus.

Press releases published on June 24, 2025

ZA Miner Unlocks Global Cloud Mining With $100 Free Bonus for New Users

ZA Miner Unlocks Global Cloud Mining With $100 Free Bonus for New Users

London, UK, June 24, 2025 (GLOBE NEWSWIRE) -- ZA Miner today announced a major update to its beginner-friendly cloud mining platform: all new users now receive a $100 sign-up bonus, enabling them to start mining crypto with zero upfront investment. The …

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Red Cat Holdings

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Red Cat Holdings

Faruqi …

Associa Houston Expo Raises $40,000 for Associa Cares While Empowering Community Leaders

Associa Houston Expo Raises $40,000 for Associa Cares While Empowering Community Leaders

HOUSTON, Texas, June 24, 2025 (GLOBE NEWSWIRE) -- Associa Houston Community Management Services (HCMS) and Associa Principal Management Group of Houston (PMGH) proudly hosted the 2025 Associa Houston Board Member Expo on Monday, May 12, 2025—a premier …

Sify Technologies announces the appointment of Dr. Ram Sewak Sharma as Director on the Board

Sify Technologies announces the appointment of Dr. Ram Sewak Sharma as Director on the Board

CHENNAI, India, June 24, 2025 (GLOBE NEWSWIRE) -- Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today …

Optimove Earns Great Place® To Work Certification™

Optimove Earns Great Place® To Work Certification™

New York, June 24, 2025 (GLOBE NEWSWIRE) -- Optimove, the leader in Positionless Marketing, is proud to be Certified™ by Great Place To Work® for the first time. The prestigious award is based entirely on what current employees say about their experience …

CBE Companies Receives 2025 BBB Torch Award for Ethics

CBE Companies Receives 2025 BBB Torch Award for Ethics

CEDAR FALLS, Iowa, June 24, 2025 (GLOBE NEWSWIRE) -- CBE Companies is honored to be named a 2025 Torch Awards for Ethics recipient by the Better Business Bureau, recognizing its commitment to ethical leadership, transparency, and long-term trust-building …

FluffCo Pillows 2025: This Hotel-Quality Pillow by FluffCo Is Taking Over American Bedrooms

FluffCo Pillows 2025: This Hotel-Quality Pillow by FluffCo Is Taking Over American Bedrooms

New York City, June 24, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of home comfort and sleep science, few brands have captured attention quite like FluffCo. Built on the idea of delivering hotel-quality sleep products to everyday consumers, the …

Life-Sized Dinosaurs Overtake the Gardens and Trails of the Lady Bird Johnson Wildflower Center

Life-Sized Dinosaurs Overtake the Gardens and Trails of the Lady Bird Johnson Wildflower Center

Austin, Texas, June 24, 2025 (GLOBE NEWSWIRE) -- Fourteen life-sized and life-like animatronic dinosaurs are lurking in the gardens and trails of the Lady Bird Johnson Wildflower Center again this summer. Last year’s Dinosaurs Around the World exhibition …

No KYC. 100x Leverage. Double Deposit Bonus. Crypto Futures Trading Made Easy on BexBack.

No KYC. 100x Leverage. Double Deposit Bonus. Crypto Futures Trading Made Easy on BexBack.

SINGAPORE , June 24, 2025 (GLOBE NEWSWIRE) -- With the price of Bitcoin fluctuating around $100,000, many analysts predict that the cryptocurrency market will remain in a state of high volatility for a long time. Holding spot positions may struggle to …

Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an

Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an

Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization CRO), hat heute eine strategische Zusammenarbeit mit Emery Pharma …

Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine

Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine

DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE) (la « Société »), une société de recherche contractuelle d’envergure mondiale (CRO) de premier plan, a annoncé aujourd’hui une collaboration stratégique avec Emery Pharma, …

Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin

Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin

DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Perusahaan”), perusahaan riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan kolaborasi strategis dengan Emery Pharma, CRO analitik dan bioanalitik terkemuka yang …

Fortrea y Emery Pharma anuncian colaboración estratégica para realizar estudios de interacción fármaco-fármaco que cumplan con la FDA utilizando rifampicina

Fortrea y Emery Pharma anuncian colaboración estratégica para realizar estudios de interacción fármaco-fármaco que cumplan con la FDA utilizando rifampicina

DURHAM, Carolina del Norte, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (la "Empresa"), una organización líder mundial en investigación por contrato (CRO), anunció hoy una colaboración estratégica con Emery Pharma, una CRO analítica y …

Fortrea ו-Emery Pharma מכריזות על שיתוף פעולה אסטרטגי לביצוע מחקרי אינטראקציה בין תרופות באמצעות ריפמפיצין, בהתאם לתקני ה-FDA

Fortrea ו-Emery Pharma מכריזות על שיתוף פעולה אסטרטגי לביצוע מחקרי אינטראקציה בין תרופות באמצעות ריפמפיצין, בהתאם לתקני ה-FDA

דורהאם, קרוליינה הצפונית, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (נאסד"ק:FTRE) ("החברה"), חברה שהיא ארגון מחקר מבוסס חוזים (CRO) גלובלית מובילה, הודיעה היום על שיתוף פעולה אסטרטגי עם Emery Pharma, חברת CRO אנליטית וביו-אנליטית מובילה המספקת שירותי בדיקה …

Fortrea dan Emery Pharma Umumkan Kerjasama Strategik untuk Menjalankan Kajian Interaksi Ubat yang Mematuhi Piawaian FDA Menggunakan Rifampin

Fortrea dan Emery Pharma Umumkan Kerjasama Strategik untuk Menjalankan Kajian Interaksi Ubat yang Mematuhi Piawaian FDA Menggunakan Rifampin

DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Syarikat”), sebuah organisasi penyelidikan kontrak (CRO) global terkemuka, hari ini mengumumkan kerjasama strategik dengan Emery Pharma, sebuah CRO analitik dan bioanalitik terkemuka …

Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA

Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA

DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje uma colaboração estratégica com a Emery Pharma, uma CRO analítica e bioanalítica líder que …

フォートリア (Fortrea) とエメリー・ファーマ (Emery Pharma)、リファンピンを用いたFDA準拠の薬物相互作用 (Drug-Drug-Interaction、DDI) 試験を提供するための戦略的提携を発表

フォートリア (Fortrea) とエメリー・ファーマ (Emery Pharma)、リファンピンを用いたFDA準拠の薬物相互作用 (Drug-Drug-Interaction、DDI) 試験を提供するための戦略的提携を発表

ノースカロライナ州ダーラム発, June 24, 2025 (GLOBE NEWSWIRE) -- グローバルな大手医薬品開発業務受託機関 (CRO) であるフォートリア (NASDAQ: FTRE)(以下「同社」) は本日、大手分析・バイオ分析CROとしてcGMPおよびGLPに準拠した試験サービスを提供するエメリー・ファーマとの戦略的提携を発表した。この提携により、薬物相互作用 (DDI) 試験で使用される主要薬剤であるリファンピンに対し、1-メチル-4-ニトロソピペラジン (MNP) …

Fortrea 與 Emery Pharma 宣佈開展戰略合作,使用利福平 (Rifampin) 開展符合 FDA 要求的藥物相互作用試驗

Fortrea 與 Emery Pharma 宣佈開展戰略合作,使用利福平 (Rifampin) 開展符合 FDA 要求的藥物相互作用試驗

達勒姆,北卡羅來納州, June 24, 2025 (GLOBE NEWSWIRE) -- 全球領先的受託研究機構 (CRO) Fortrea (Nasdaq: FTRE)(下稱「公司」)今天宣佈與 Emery Pharma 建立戰略合作關係。Emery Pharma 是一家領先的分析和生物分析受託研究機構,根據現行的《良好生產規範》(cGMP) 和《藥物非臨床研究品質管理規範》(GLP) 提供測試服務。Fortrea 與 Emery Pharma 的戰略合作將為藥物相互作用 (DDI) …

Fortrea, Emery Pharma와 협력해 FDA 기준에 맞춰 리팜핀 사용 가능한 DDI 연구 지원

Fortrea, Emery Pharma와 협력해 FDA 기준에 맞춰 리팜핀 사용 가능한 DDI 연구 지원

노스캐롤라이나주 더럼, June 24, 2025 (GLOBE NEWSWIRE) -- 글로벌 임상시험수탁기관(CRO) Fortrea(나스닥명: FTRE)(이하 “회사”)가 Emery Pharma와 전략적 협력을 발표했다. Emery Pharma는 현행우수제조관리기준(cGMP)과 우수실험실운영기준(GLP)에 맞춰 테스트 서비스를 제공하며 업계를 선도하는 분석 및 생체시료 분석 CRO로, 약물상호작용(DDI) 연구에서 선호되는 리팜핀을 대상으로 로트별 1-메틸 …

Fortrea และ Emery Pharma ประกาศความร่วมมือเชิงกลยุทธ์เพื่อดำเนินการศึกษาวิจัยอันตรกิริยาระหว่างยาที่สอดคล้องกับ FDA โดยใช้ยาไรแฟมปิน (Rifampin…

Fortrea และ Emery Pharma ประกาศความร่วมมือเชิงกลยุทธ์เพื่อดำเนินการศึกษาวิจัยอันตรกิริยาระหว่างยาที่สอดคล้องกับ FDA โดยใช้ยาไรแฟมปิน (Rifampin…

เดอร์แฮม, รัฐนอร์ทแคโรไลนา, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“บริษัท”) ซึ่งเป็นองค์กรวิจัยตามสัญญา (Contract Research Organization, CRO) ทางคลินิกชั้นนำระดับโลก ได้ประกาศวันนี้ถึงความร่วมมือเชิงกลยุทธ์กับ Emery Pharma ซึ่งเป็น CRO …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service